Ascentage Pharma Group International (AAPG) Short Interest Ratio & Short Volume

Short interest is the volume of Ascentage Pharma Group International shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 15,300 shares of AAPG short. 0.02% of Ascentage Pharma Group International's shares are currently sold short. Learn More on Ascentage Pharma Group International's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AAPG shares currently have a short interest ratio of 1.0. Learn More on Ascentage Pharma Group International's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.02% of Ascentage Pharma Group International's floating shares are currently sold short.

Ascentage Pharma Group International saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 15,300 shares, a decrease of 9.5% from the previous total of 16,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.02% of Ascentage Pharma Group International's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Ascentage Pharma Group International: Ascendis Pharma A/S (7.30%), Viatris Inc. (3.56%), Dr. Reddy's Laboratories Ltd (1.16%), QIAGEN N.V. (3.13%), BridgeBio Pharma, Inc. (12.73%), Moderna, Inc. (17.42%), Verona Pharma PLC American Depositary Share (2.44%), Elanco Animal Health Incorporated (5.24%), Roivant Sciences Ltd. (9.04%), Revolution Medicines, Inc. (9.63%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.23 billion), Invesco QQQ ($29.52 billion), iShares Russell 2000 ETF ($20.82 billion), iShares 20+ Year Treasury Bond ETF ($10.76 billion), Palo Alto Networks, Inc. ($9.37 billion), Strategy Inc ($7.58 billion), Invesco S&P 500 Equal Weight ETF ($6.78 billion), SPDR S&P Biotech ETF ($6.72 billion), AppLovin Corporation ($6.37 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($6.29 billion). View all of the most shorted stocks.

Short selling AAPG is an investing strategy that aims to generate trading profit from Ascentage Pharma Group International as its price is falling. AAPG shares are trading up $0.57 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Ascentage Pharma Group International occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AAPG, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AAPG, twice per month. The most recent reporting period available is August, 31 2025.